Comparisons of the effects of misoprostol by two different application on the treatment of missed abortion

Chinese Journal of Pharmaceutical Biotechnology

Volumn 21, Issue 2, 2014, Pages 159-161

  Lu, Pin Hong ^a   Lu, Jing ^a   Zou, Shan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Mifepristone; Misoprostol; Missed abortion

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ARTICLE; CONTROLLED STUDY; DILATION AND EVACUATION; DRUG EFFECT; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MISSED ABORTION; MORNING DOSAGE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX DILATATION;

EID: 84904891800     PISSN: 10058915     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. 2007, 47(11): 787.
2. 2005, 24(3): 105.
3. 2012, 28(8): 693.
4. 2012, 14(4): 439.
5. Tang O S, Schweer H, Seyberth H W, et al. Pharmacokinetics of different routes of administration of misoprostol[J]. Hum Reprod, 2002, 17(2): 332.
6. Ashok P W, Templeton A, Wagaarachchi P T, et al. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases[J]. Contraception, 2004, 69(1): 51.
7. Niinimaki M, Jouppila P, Martikainen H, et al. A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage[J]. Fertil Steril, 2006, 86 (2): 367.
8. Honkanen H, Piaggio G, Hertzen H, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion[J]. BJOG, 2004, 111(7): 715.